「fo」の検索結果
123件：101～105件目を表示
-
お知らせ | 千寿製薬株式会社
se through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
https://www.senju.co.jp/chinese/news/ -
お知らせ | 千寿製薬株式会社
se through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
http://www.senju.co.jp/chinese/news/ -
l Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
l Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO EXα Works on unbearable eye itching due to pollens and other ...
http://www.senju.co.jp/english/products/apex.html